Table 1: Characteristics of overall study population, nontransfused and transfused patients.

Overall ( 𝑛 = 7 6 )Nontransfused ( 𝑛 = 5 1 )Transfused ( 𝑛 = 2 5 )P

Male (n, %)55 (72)33 (65)22 (88)0.054a
Age (years)c49 ± 2152 ± 2043 ± 200.056b
Blunt mechanism (n, %)63 (83)42 (82)21 (84)0.543b
Systolic BP (mmHg)127 ± 23130 ± 22122 ± 250.111b
Diastolic BP (mmHg)73 ± 1975 ± 2070 ± 160.399b
Heart rate (bpm)84 ± 2178 ± 1798 ± 250.005 b
Lactate (mmol/L)2.3 ± 1.82.0 ± 1.33.0 ± 2.40.070b
Base deficit (mEq/L)−2.7 ± 3.3−1.9 ± 2.1−3.8 ± 4.40.099b
Hb (g/dL)12.4 ± 2.313.1 ± 2.010.9 ± 2.4<0.001
Hct (%)36.5 ± 6.838.5 ± 5.832.3 ± 6.9<0.001
ISS18 ± 1015 ± 924 ± 100.001 b
Craniocerebral injury (n, %)33 (43)20 (39)13 (52)0.285b
Mortality (n, %)9 (12)1 (2)8 (32)<0.001 a
ICU admission (n, %)34 (45)16 (31)18 (72)0.001 a
APACHE II score (ICU pts)19.7 ± 8.316.9 ± 8.022.3 ± 7.80.078b
SAPS II40 ± 1934 ± 1745 ± 200.101b

aFisher’s exact test.
bKruskal-Wallis test.
cPresented as (mean ± SD) for continuous variables, unless otherwise indicated.